Table 2.
Treatment | Total | AQPR | ETF | LPF | LCF | ||||
---|---|---|---|---|---|---|---|---|---|
Nº | % | Nº | % | Nº | % | Nº | % | ||
amodiaquine + sulphadoxine-pyrimethamine | 114 | 110 | 96.5 | 0 | 0.0 | 4 | 3.5 | 0 | 0.0 |
artesunate + sulphadoxine-pyrimethamine | 79 | 77 | 97.5 | 0 | 0.0 | 2 | 2.5 | 0 | 0.0 |
Treatment | Total | AQPR | ETF | LPF | LCF | ||||
---|---|---|---|---|---|---|---|---|---|
Nº | % | Nº | % | Nº | % | Nº | % | ||
amodiaquine + sulphadoxine-pyrimethamine | 114 | 110 | 96.5 | 0 | 0.0 | 4 | 3.5 | 0 | 0.0 |
artesunate + sulphadoxine-pyrimethamine | 79 | 77 | 97.5 | 0 | 0.0 | 2 | 2.5 | 0 | 0.0 |